Skip to main content
Top
Published in: Nutrition & Metabolism 1/2010

Open Access 01-12-2010 | Research

Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation

Authors: Ivana Dostálová, Petra Kaválková, Hana Papežová, Daniela Domluvilová, Vít Zikán, Martin Haluzík

Published in: Nutrition & Metabolism | Issue 1/2010

Login to get access

Abstract

Background

Macrophage inhibitory cytokine-1 (MIC-1) is a key inducer of cancer-related anorexia and weight loss. However, its possible role in the etiopathogenesis of nutritional disorders of other etiology such as anorexia nervosa (AN) is currently unknown.

Methods

We measured fasting serum concentrations of MIC-1 in patients with AN before and after 2-month nutritional treatment and explored its relationship with nutritional status, metabolic and biochemical parameters. Sixteen previously untreated women with AN and twenty-five normal-weight age-matched control women participated in the study. We measured serum concentrations of MIC-1 and leptin by ELISA, free fatty acids by enzymatic colorimetric assay, and biochemical parameters by standard laboratory methods; determined resting energy expenditure by indirect calorimetry; and assessed bone mineral density and body fat content by dual-energy X-ray absorptiometry. ANOVA, unpaired t-test or Mann-Whitney test were used for groups comparison as appropriate. The comparisons of serum MIC-1 levels and other studied parameters in patients with AN before and after partial realimentation were assessed by paired t-test or Wilcoxon Signed Rank Test as appropriate.

Results

At baseline, fasting serum MIC-1 concentrations were significantly higher in patients with AN relative to controls. Partial realimentation significantly reduced serum MIC-1 concentrations in patients with AN but it still remained significantly higher compared to control group. In AN group, serum MIC-1 was inversely related to Buzby nutritional risk index, serum insulin-like growth factor-1, serum glucose, serum total protein, serum albumin, and lumbar bone mineral density and it significantly positively correlated with the duration of AN and age.

Conclusions

MIC-1 concentrations in AN patients are significantly higher relative to healthy women. Partial realimentation significantly decreased MIC-1 concentration in AN group. Clinical significance of these findings needs to be further clarified.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington, DC: American Psychiatric Press, 4 American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington, DC: American Psychiatric Press, 4
2.
go back to reference Bulik CM, Reba L, Siega-Riz AM, Reichborn-Kjennerud T: Anorexia nervosa: definition, epidemiology, and cycle of risk. Int J Eat Disord. 2005, 37: S2-S9. 10.1002/eat.20107.CrossRef Bulik CM, Reba L, Siega-Riz AM, Reichborn-Kjennerud T: Anorexia nervosa: definition, epidemiology, and cycle of risk. Int J Eat Disord. 2005, 37: S2-S9. 10.1002/eat.20107.CrossRef
3.
go back to reference Monteleone P, Castaldo E, Maj M: Neuroendocrine dysregulation of food intake in eating disorders. Regul Pept. 2008, 149: 39-50. 10.1016/j.regpep.2007.10.007.CrossRef Monteleone P, Castaldo E, Maj M: Neuroendocrine dysregulation of food intake in eating disorders. Regul Pept. 2008, 149: 39-50. 10.1016/j.regpep.2007.10.007.CrossRef
4.
go back to reference Yanovski SZ: Biological correlates of binge eating. Addict Behav. 1995, 20: 705-712. 10.1016/0306-4603(96)00092-5.CrossRef Yanovski SZ: Biological correlates of binge eating. Addict Behav. 1995, 20: 705-712. 10.1016/0306-4603(96)00092-5.CrossRef
5.
go back to reference Nedvídková J, Krykorková I, Barták V, Papezová H, Gold PW, Alesci S, Pacak K: Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab. 2003, 88: 1678-1682. 10.1210/jc.2002-021669.CrossRef Nedvídková J, Krykorková I, Barták V, Papezová H, Gold PW, Alesci S, Pacak K: Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab. 2003, 88: 1678-1682. 10.1210/jc.2002-021669.CrossRef
6.
go back to reference Dostálová I, Kopský V, Dusková J, Papezová H, Pacák K, Nedvídková J: Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Regul Pept. 2005, 128: 63-68. 10.1016/j.regpep.2004.12.029.CrossRef Dostálová I, Kopský V, Dusková J, Papezová H, Pacák K, Nedvídková J: Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Regul Pept. 2005, 128: 63-68. 10.1016/j.regpep.2004.12.029.CrossRef
7.
go back to reference Housova J, Anderlova K, Krizová J, Haluzikova D, Kremen J, Kumstyrová T, Papezová H, Haluzik M: Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab. 2005, 90: 1366-1370. 10.1210/jc.2004-1364.CrossRef Housova J, Anderlova K, Krizová J, Haluzikova D, Kremen J, Kumstyrová T, Papezová H, Haluzik M: Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab. 2005, 90: 1366-1370. 10.1210/jc.2004-1364.CrossRef
8.
go back to reference Hillebrand JJ, Koeners MP, de Rijke CE, Kas MJ, Adan RA: Leptin treatment in activity-based anorexia. Biol Psychiatry. 2005, 58: 165-171. 10.1016/j.biopsych.2005.03.011.CrossRef Hillebrand JJ, Koeners MP, de Rijke CE, Kas MJ, Adan RA: Leptin treatment in activity-based anorexia. Biol Psychiatry. 2005, 58: 165-171. 10.1016/j.biopsych.2005.03.011.CrossRef
9.
go back to reference Gorden P, Park JY: The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction. Arch Physiol Chem. 2006, 112: 114-118.CrossRef Gorden P, Park JY: The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction. Arch Physiol Chem. 2006, 112: 114-118.CrossRef
10.
go back to reference Dostálová I, Kaválková P, Haluzíková D, Lacinová Z, Mráz M, Papezová H, Haluzík M: Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J Clin Endocrinol Metab. 2008, 93: 3627-3632. 10.1210/jc.2008-0746.CrossRef Dostálová I, Kaválková P, Haluzíková D, Lacinová Z, Mráz M, Papezová H, Haluzík M: Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J Clin Endocrinol Metab. 2008, 93: 3627-3632. 10.1210/jc.2008-0746.CrossRef
11.
go back to reference Dubuc GR, Phinney SD, Stern JS, Havel PJ: Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism. 1998, 47: 429-434. 10.1016/S0026-0495(98)90055-5.CrossRef Dubuc GR, Phinney SD, Stern JS, Havel PJ: Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism. 1998, 47: 429-434. 10.1016/S0026-0495(98)90055-5.CrossRef
12.
go back to reference Havel PJ: Leptin production and action: relevance to energy balance in humans. Am J Clin Nutr. 1998, 67: 355-356. Havel PJ: Leptin production and action: relevance to energy balance in humans. Am J Clin Nutr. 1998, 67: 355-356.
13.
go back to reference Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW: Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord. 2003, 27: 875-888. 10.1038/sj.ijo.0802326.CrossRef Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW: Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord. 2003, 27: 875-888. 10.1038/sj.ijo.0802326.CrossRef
14.
go back to reference Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN: MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA. 1997, 94: 11514-11519. 10.1073/pnas.94.21.11514.CrossRef Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN: MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA. 1997, 94: 11514-11519. 10.1073/pnas.94.21.11514.CrossRef
15.
go back to reference Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P, Bing C: Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology. 2009, 150: 1688-1696. 10.1210/en.2008-0952.CrossRef Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P, Bing C: Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology. 2009, 150: 1688-1696. 10.1210/en.2008-0952.CrossRef
16.
go back to reference Böttner M, Suter-Crazzolara C, Schober A, Unsicker K: Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res. 1999, 297: 103-110. 10.1007/s004410051337.CrossRef Böttner M, Suter-Crazzolara C, Schober A, Unsicker K: Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res. 1999, 297: 103-110. 10.1007/s004410051337.CrossRef
17.
go back to reference Schober A, Böttner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN, Unsicker K: Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol. 2001, 439: 32-45. 10.1002/cne.1333.CrossRef Schober A, Böttner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN, Unsicker K: Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol. 2001, 439: 32-45. 10.1002/cne.1333.CrossRef
18.
go back to reference Fairlie WD, Zhang HP, Wu WM, Pankhurst SL, Bauskin AR, Russell PK, Brown PK, Breit SN: The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion. J Biol Chem. 2001, 276: 16911-16918. 10.1074/jbc.M010000200.CrossRef Fairlie WD, Zhang HP, Wu WM, Pankhurst SL, Bauskin AR, Russell PK, Brown PK, Breit SN: The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion. J Biol Chem. 2001, 276: 16911-16918. 10.1074/jbc.M010000200.CrossRef
19.
go back to reference Moore AG, Brown DA, Fairlie WD, Bauskin AR, Brown PK, Munier ML, Russell PK, Salamonsen LA, Wallace EM, Breit SN: The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab. 2000, 85: 4781-4788. 10.1210/jc.85.12.4781. Moore AG, Brown DA, Fairlie WD, Bauskin AR, Brown PK, Munier ML, Russell PK, Salamonsen LA, Wallace EM, Breit SN: The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab. 2000, 85: 4781-4788. 10.1210/jc.85.12.4781.
20.
go back to reference Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, Johnen H, Russell PJ, Barret W, Stricker PD, Grygiel JJ, Kench JG, Henshall SM, Sutherland RL, Breit SN: The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res. 2005, 65: 2330-2336. 10.1158/0008-5472.CAN-04-3827.CrossRef Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, Johnen H, Russell PJ, Barret W, Stricker PD, Grygiel JJ, Kench JG, Henshall SM, Sutherland RL, Breit SN: The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res. 2005, 65: 2330-2336. 10.1158/0008-5472.CAN-04-3827.CrossRef
21.
go back to reference Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T, Weedon H, Milliken ST, Tak PP, Smith MD, Breit SN: Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum. 2007, 56: 753-764. 10.1002/art.22410.CrossRef Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T, Weedon H, Milliken ST, Tak PP, Smith MD, Breit SN: Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum. 2007, 56: 753-764. 10.1002/art.22410.CrossRef
22.
go back to reference Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, Bauskin AR, Kinzler KW, Vogelstein B, Breit SN: MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res. 2003, 9: 2642-2650. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, Bauskin AR, Kinzler KW, Vogelstein B, Breit SN: MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res. 2003, 9: 2642-2650.
23.
go back to reference Wollmann W, Goodman ML, Bhat-Nakshatri P, Kishimoto H, Goulet RJ, Mehrotra S, Morimiya A, Badve S, Nakshatri H: The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis. 2005, 26: 900-907. 10.1093/carcin/bgi031.CrossRef Wollmann W, Goodman ML, Bhat-Nakshatri P, Kishimoto H, Goulet RJ, Mehrotra S, Morimiya A, Badve S, Nakshatri H: The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis. 2005, 26: 900-907. 10.1093/carcin/bgi031.CrossRef
24.
go back to reference Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M, Breit SN: Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res. 2006, 66: 4983-4986. 10.1158/0008-5472.CAN-05-4067.CrossRef Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M, Breit SN: Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res. 2006, 66: 4983-4986. 10.1158/0008-5472.CAN-05-4067.CrossRef
25.
go back to reference Koopmann J, Rosenzweig CN, Zhang Z, Canto MI, Brown DA, Hunter M, Yeo C, Chan DW, Breit SN, Goggins M: Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin Cancer Res. 2006, 12: 442-446. 10.1158/1078-0432.CCR-05-0564.CrossRef Koopmann J, Rosenzweig CN, Zhang Z, Canto MI, Brown DA, Hunter M, Yeo C, Chan DW, Breit SN, Goggins M: Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin Cancer Res. 2006, 12: 442-446. 10.1158/1078-0432.CCR-05-0564.CrossRef
26.
go back to reference Wakchoure S, Swain TM, Hentunen TA, Bauskin AR, Brown DA, Breit SN, Vuopala KS, Harris KW, Selander KS: Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss. Prostate. 2009, 69: 652-661. 10.1002/pros.20913.CrossRef Wakchoure S, Swain TM, Hentunen TA, Bauskin AR, Brown DA, Breit SN, Vuopala KS, Harris KW, Selander KS: Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss. Prostate. 2009, 69: 652-661. 10.1002/pros.20913.CrossRef
27.
go back to reference Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T, Ridker PM: Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet. 2002, 359: 2159-2163. 10.1016/S0140-6736(02)09093-1.CrossRef Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T, Ridker PM: Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet. 2002, 359: 2159-2163. 10.1016/S0140-6736(02)09093-1.CrossRef
28.
go back to reference Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL: Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J. 2009, 30: 1057-1065. 10.1093/eurheartj/ehn600.CrossRef Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL: Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J. 2009, 30: 1057-1065. 10.1093/eurheartj/ehn600.CrossRef
29.
go back to reference Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG: Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock. 2005, 23: 543-548. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG: Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock. 2005, 23: 543-548.
30.
go back to reference Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN: Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med. 2007, 13: 1333-1340. 10.1038/nm1677.CrossRef Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN: Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med. 2007, 13: 1333-1340. 10.1038/nm1677.CrossRef
31.
go back to reference Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M: Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005, 90: 2920-2926. 10.1210/jc.2004-1788.CrossRef Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M: Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005, 90: 2920-2926. 10.1210/jc.2004-1788.CrossRef
32.
go back to reference Buzby GP, Knox LS, Crosby LO, Eisenberg JM, Haakenson CM, McNeal GE, Page CP, Peterson OL, Reinhardt GF, Williford WO: Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr. 1988, 47: 366-381. Buzby GP, Knox LS, Crosby LO, Eisenberg JM, Haakenson CM, McNeal GE, Page CP, Peterson OL, Reinhardt GF, Williford WO: Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr. 1988, 47: 366-381.
33.
go back to reference Usdan LS, Khaodhiar L, Apovian CM: The endocrinopathies of anorexia nervosa. Endocr Pract. 2008, 14: 1055-1063.CrossRef Usdan LS, Khaodhiar L, Apovian CM: The endocrinopathies of anorexia nervosa. Endocr Pract. 2008, 14: 1055-1063.CrossRef
34.
go back to reference Jacoangeli F, Masala S, Staar Mezzasalma F, Fiori R, Martinetti A, Ficoneri C, Novi B, Pierangeli S, Marchetti G, Simonetti G, Bollea MR: Amenorrhea after weight recover in anorexia nervosa: role of body composition and endocrine abnormalities. Eat Weight Disord. 2006, 11: e20-26.CrossRef Jacoangeli F, Masala S, Staar Mezzasalma F, Fiori R, Martinetti A, Ficoneri C, Novi B, Pierangeli S, Marchetti G, Simonetti G, Bollea MR: Amenorrhea after weight recover in anorexia nervosa: role of body composition and endocrine abnormalities. Eat Weight Disord. 2006, 11: e20-26.CrossRef
35.
go back to reference Wentz E, Mellström D, Gillberg C, Sundh V, Gillberg IC, Råstam M: Bone density 11 years after anorexia nervosa onset in a controlled study of 39 cases. Int J Eat Disord. 2003, 34: 314-318. 10.1002/eat.10192.CrossRef Wentz E, Mellström D, Gillberg C, Sundh V, Gillberg IC, Råstam M: Bone density 11 years after anorexia nervosa onset in a controlled study of 39 cases. Int J Eat Disord. 2003, 34: 314-318. 10.1002/eat.10192.CrossRef
36.
go back to reference Schneider M, Fisher M, Weinerman S, Lesser M: Correlates of low bone density in females with anorexia nervosa. Int J Adolesc Med Health. 2002, 14: 297-306.CrossRef Schneider M, Fisher M, Weinerman S, Lesser M: Correlates of low bone density in females with anorexia nervosa. Int J Adolesc Med Health. 2002, 14: 297-306.CrossRef
37.
go back to reference Monteleone P, Martiadis V, Colurcio B, Maj M: Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Psychosom Med. 2002, 64: 874-879. 10.1097/01.PSY.0000024239.11538.A5. Monteleone P, Martiadis V, Colurcio B, Maj M: Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Psychosom Med. 2002, 64: 874-879. 10.1097/01.PSY.0000024239.11538.A5.
38.
go back to reference Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK: Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study. Eur J Clin Nutr. 2003, 57: 1262-1267. 10.1038/sj.ejcn.1601683.CrossRef Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK: Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study. Eur J Clin Nutr. 2003, 57: 1262-1267. 10.1038/sj.ejcn.1601683.CrossRef
39.
go back to reference Winston AP, Alwazeer AE, Bankart MJ: Screening for osteoporosis in anorexia nervosa: prevalence and predictors of reduced bone mineral density. Int J Eat Disord. 2008, 41: 284-287. 10.1002/eat.20501.CrossRef Winston AP, Alwazeer AE, Bankart MJ: Screening for osteoporosis in anorexia nervosa: prevalence and predictors of reduced bone mineral density. Int J Eat Disord. 2008, 41: 284-287. 10.1002/eat.20501.CrossRef
40.
go back to reference Hay PJ, Delahunt JW, Hall A, Mitchell AW, Harper G, Salmond C: Predictors of osteopenia in premenopausal women with anorexia nervosa. Calcif Tissue Int. 1992, 50: 498-501. 10.1007/BF00582161.CrossRef Hay PJ, Delahunt JW, Hall A, Mitchell AW, Harper G, Salmond C: Predictors of osteopenia in premenopausal women with anorexia nervosa. Calcif Tissue Int. 1992, 50: 498-501. 10.1007/BF00582161.CrossRef
41.
go back to reference Utz AL, Lawson EA, Misra M, Mickley D, Gleysteen S, Herzog DB, Klibanski A, Miller KK: Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone. 2008, 43: 135-139. 10.1016/j.bone.2008.03.007.CrossRef Utz AL, Lawson EA, Misra M, Mickley D, Gleysteen S, Herzog DB, Klibanski A, Miller KK: Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone. 2008, 43: 135-139. 10.1016/j.bone.2008.03.007.CrossRef
42.
go back to reference Dostálová I, Roubícek T, Bártlová M, Mráz M, Lacinová Z, Haluzíková D, Kaválková P, Matoulek M, Kasalicky M, Haluzík M: Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur J Endocrinol. 2009, 161: 397-404. 10.1530/EJE-09-0417.CrossRef Dostálová I, Roubícek T, Bártlová M, Mráz M, Lacinová Z, Haluzíková D, Kaválková P, Matoulek M, Kasalicky M, Haluzík M: Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur J Endocrinol. 2009, 161: 397-404. 10.1530/EJE-09-0417.CrossRef
43.
go back to reference Fortunati N, Manti R, Birocco N, Pugliese M, Brignardello E, Ciuffreda L, Catalano MG, Aragno M, Boccuzzi G: Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Oncol Rep. 2007, 18: 1521-1527. Fortunati N, Manti R, Birocco N, Pugliese M, Brignardello E, Ciuffreda L, Catalano MG, Aragno M, Boccuzzi G: Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Oncol Rep. 2007, 18: 1521-1527.
44.
go back to reference Roberts CK, Sindhu KK: Oxidative stress and metabolic syndrome. Life Sci. 2009, 84: 705-712. 10.1016/j.lfs.2009.02.026.CrossRef Roberts CK, Sindhu KK: Oxidative stress and metabolic syndrome. Life Sci. 2009, 84: 705-712. 10.1016/j.lfs.2009.02.026.CrossRef
45.
go back to reference Beattie JH, Wood AM, Newman AM, Bremner I, Choo KH, Michalska AE, Duncan JS, Trayhurn P: Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci USA. 1998, 95: 358-363. 10.1073/pnas.95.1.358.CrossRef Beattie JH, Wood AM, Newman AM, Bremner I, Choo KH, Michalska AE, Duncan JS, Trayhurn P: Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci USA. 1998, 95: 358-363. 10.1073/pnas.95.1.358.CrossRef
46.
go back to reference Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D, Papezova H, Haluzik M: Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin Endocrinol (Oxf). 2007, 67: 674-678. 10.1111/j.1365-2265.2007.02944.x.CrossRef Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D, Papezova H, Haluzik M: Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin Endocrinol (Oxf). 2007, 67: 674-678. 10.1111/j.1365-2265.2007.02944.x.CrossRef
47.
go back to reference Dolinková M, Dostálová I, Lacinová Z, Michalský D, Haluzíková D, Mráz M, Kasalický M, Haluzík M: The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol. 2008, 291: 63-70. 10.1016/j.mce.2008.05.001.CrossRef Dolinková M, Dostálová I, Lacinová Z, Michalský D, Haluzíková D, Mráz M, Kasalický M, Haluzík M: The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol. 2008, 291: 63-70. 10.1016/j.mce.2008.05.001.CrossRef
48.
go back to reference Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG: Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. J Surg Res. 2006, 130: 45-51. 10.1016/j.jss.2005.07.036.CrossRef Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG: Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. J Surg Res. 2006, 130: 45-51. 10.1016/j.jss.2005.07.036.CrossRef
Metadata
Title
Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation
Authors
Ivana Dostálová
Petra Kaválková
Hana Papežová
Daniela Domluvilová
Vít Zikán
Martin Haluzík
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2010
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-7-34

Other articles of this Issue 1/2010

Nutrition & Metabolism 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.